ELEVANCE HEALTH INC (ELV)
US0367521038 - Common Stock
See Which Of The Latest 13F Filers Holds Elevance Health
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
How To YieldBoost Elevance Health From 1.2% To 5.8% Using Options
3 Healthcare Stocks to Buy Now: Q2 Edition
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.
Noteworthy Thursday Option Activity: COF, ELV, AZO
Thursday Sector Leaders: Financial, Consumer Products
Elevance Health (ELV) Q1 2024 Earnings Call Transcript
ELV earnings call for the period ending March 31, 2024.
ELV Stock Earnings: Elevance Health Beats EPS, Misses Revenue for Q1 2024
ELV stock results show that Elevance Health beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Elevance Beats Estimates, Raises Forecast on Low Medical Costs
Elevance Health Inc. raised its outlook for the year on first-quarter results that offered some relief to investors after a cyberattack against a rival roiled the health-insurance sector.
Elevance Health Reports First Quarter 2024 Results
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
S&P 500 Analyst Moves: ELV
UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates
Final Medicare Advantage rates were unchanged vs. the initial proposal.
Insurers to Cover Novo’s Wegovy for Some Medicare Heart Patients
Major health insurers will now cover Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy for certain Medicare beneficiaries with heart-related conditions.
Elevance Health Announces Closing of Paragon Healthcare Acquisition